Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: Results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Study

Psychiatry Research

Volumn 190, Issue 1, 2011, Pages 110-114

  Hong, Jihyung ^a,b   Reed, Catherine ^b   Novick, Diego ^b   Haro, Josep Maria ^c   Aguado, Jaume ^c  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cost; Patient non adherence; Treatment outcome

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DRUG COST; EUROPE; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; RELAPSE; REMISSION; SUICIDE ATTEMPT;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; EUROPE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES;

EID: 83655201510     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.04.016     Document Type: Article

References (39)

1. Andrade S.E., Kahler K.H., Frech F., Chan K.A. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol. Drug Saf. 2006, 15:565-574. discussion 575-567.
2. Baldessarini R.J., Perry R., Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum. Psychopharmacol. 2008, 23:95-105.
3. British National Formulary, 2008. BNF 55.
4. Colom F., Vieta E. Non-adherence in psychiatric disorders: misbehaviour or clinical feature? Acta Psychiatr. Scand. 2002, 105:161-163.
5. Colom F., Vieta E., Martinez-Aran A., Reinares M., Benabarre A., Gasto C. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J. Clin. Psychiatry 2000, 61:549-555.
6. Colom F., Vieta E., Tacchi M.J., Sanchez-Moreno J., Scott J. Identifying and improving non-adherence in bipolar disorders. Bipolar Disord. 2005, 7(Suppl 5):24-31.
7. Curtis L. Unit Costs of Health and Social Care 2008 2008, PSSRU University of Canterbury.
8. Efron B. An Introduction to the Bootstrap 1993, Chapman & Hall, New York.
9. Gianfrancesco F.D., Sajatovic M., Rajagopalan K., Wang R.-H. Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorder. Clin. Ther. 2008, 30:1358-1374.
10. Goetz I., Tohen M., Reed C., Lorenzo M., Vieta E. Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord. 2007, 9:45-52.
11. Gonzalez-Pinto A., Ballesteros J., Aldama A., Perez de Heredia J.L., Gutierrez M., Mosquera F. Principal components of mania. J. Affect. Disord. 2003, 76:95-102.
12. Gonzalez-Pinto A., Mosquera F., Alonso M., Lopez P., Ramirez F., Vieta E., Baldessarini R.J. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord. 2006, 8:618-624.
13. Gonzalez-Pinto A., Mosquera F., Reed C., Novick D., Barbeito S., Vega P., Bertsch J., Alberich S., Haro J.M. Validity and reliability of the Hamilton depression rating scale (5 items) for manic and mixed bipolar disorders. J. Nerv. Ment. Dis. 2009, 197:682-686.
14. Goodwin F.K., Fireman B., Simon G.E., Hunkeler E.M., Lee J., Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003, 290:1467-1473.
15. Haro J.M., van Os J., Vieta E., Reed C., Lorenzo M., Goetz I., Board E.A. Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study. Acta Psychiatr. Scand. 2006, 113:112-120.
16. Harvey P.D. Defining and achieving recovery from bipolar disorder. J. Clinical Psychiatry 67 Suppl 2006, 9:14-18. discussion 36-42.
17. IMS Health Inc., Q4/2007. MIDAS®.
18. Lingam R., Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr. Scand. 2002, 105:164-172.
19. Little R., Rubin D. Statistical Analysis with Missing Data 1987, John Wiley, New York.
20. Mander A.J. Is there a lithium withdrawal syndrome? Br. J. Psychiatry 1986, 149:498-501.
21. Mander A.J. Use of lithium and early relapse in manic-depressive illness. Acta Psychiatr. Scand. 1988, 78:198-200.
22. Mander A.J., Loudon J.B. Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet 1988, 2:15-17.
23. Mennemeyer S.T., Cyr L.P. A bootstrap approach to medical decision analysis. J. Health Econ. 1997, 16:741-747.
24. Muller-Oerlinghausen B., Muser-Causemann B., Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J. Affect. Disord. 1992, 25:261-269.
25. Muller-Oerlinghausen B., Wolf T., Ahrens B., Glaenz T., Schou M., Grof E., Grof P., Lenz G., Simhandl C., Thau K., Vestergaard P., Wolf R. Mortality of patients who dropped out from regular lithium prophylaxis: a collaborative study by the International Group for the Study of Lithium-treated patients (IGSLI). Acta Psychiatr. Scand. 1996, 94:344-347.
26. National Collaborating Centre for Mental Health. Commissioned by the National Institute for Health and Clinical Excellence. monograph online 2006, National Institute for Health and Clinical Excellence, London.
27. Pompili M., Serafini G., Del Casale A., Rigucci S., Innamorati M., Girardi P., Tatarelli R., Lester D. Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk. Expert Rev. Neurother. 2009, 9:985-1004.
28. Rubin D. Multiple Imputation for Nonresponse in Surveys 1987, John Wiley & Sons, New York.
29. Schafer J. Analysis of Incomplete Multivariate Data 1997, Chapman & Hall, London DC.
30. Schumann C., Lenz G., Berghofer A., Muller-Oerlinghausen B. Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatry Res. 1999, 89:247-257.
31. Scott J., Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J. Clin. Psychiatry 2002, 63:384-390.
32. Scott J., Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am. J. Psychiatry 2002, 159:1927-1929.
33. Spearing M.K., Post R.M., Leverich G.S., Brandt D., Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997, 73:159-171.
34. Strober M., Morrell W., Lampert C., Burroughs J. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. Am. J. Psychiatry 1990, 147:457-461.
35. Svarstad B.L., Shireman T.I., Sweeney J.K. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr. Serv. 2001, 52:805-811.
36. Taylor D., Paton C., Kerwin R. The Maudsley 2005-2006 prescribing guidelines (8th ed.) 2005, Taylor and Francis, London.
37. Tohen M., Frank E., Bowden C.L., Colom F., Ghaemi S.N., Yatham L.N., Malhi G.S., Calabrese J.R., Nolen W.A., Vieta E., Kapczinski F., vio x00E, Goodwin G.M., Suppes T., Sachs G.S., Chengappa K.R., Grunze H., Mitchell P.B., Kanba S., Berk M. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009, 11:453-473.
38. Vieta E. Improving treatment adherence in bipolar disorder through psychoeducation. J. Clin. Psychiatry 2005, 66(Suppl 1):24-29.
39. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.